Âé¶¹¹û¶³

Cellular & Molecular Faculty

NameEmailCampusSpecialty
Sanjaya Abeysirigunawardenasabeysir@kent.eduKent
Mohammad Ansarimansari1@neomed.eduNEOMED
Julie Aultmanjmaultma@neomed.eduNEOMED
Joseph Bedontjbedont@kent.eduKentsleep; circadian rhythms; metabolism; autophagy; polyamines; nitrogen stress. More on Bedont
Heather Caldwellhcaldwel@kent.eduKentRole of neuropeptides in regulating social behaviors and neuropsychiatric disorders. More on Caldwell
Peiwen Chenchenp6@ccf.orgCCF
Yeong-Renn Chenychen1@neomed.eduNEOMEDOxygen free radicals, Nitric oxide, oxidative postranslational modifications, mitochondrial biology in myocardial infarction.
Chi-hua Chiu Groffcchiu5@kent.eduKentMore on Chiu Groff
Wilson Chungwchung@kent.eduKentNeuroendocrine brain, androgens, fibroblast growth factor signaling. More on Chung
Robert Clementsrclement@kent.eduKentMore on Clements
Lisa Cooperlcooper@neomed.eduNEOMED
Dimitrios Davalosdavalod@ccf.orgCCFThe Dimitrios Davalos lab studies the interactions between blood vessels, neurons and microglia in health and disease.
Christine Dengler-Crishccrish@neomed.eduNEOMEDEarly disease mechanisms in dementia; sensory system disruptions and homeostatic dysregulation in Alzheimer's disease.
Feng Dongfdong@neomed.eduNEOMED
Jean Engohang-Ndongjengohan@kent.eduKentMore on Engohang-Ndong
Jessica Ferrelljfrancl@neomed.eduNEOMEDLong-term research interests lie in examining the pathological disruptions to bile acid physiology that contribute to alcoholic- and non-alcoholic fatty liver disease. We are also interested in studying the interactions between liver/gut metabolism and Alzheimer’s disease, as Type 2 diabetes, cholesterol homeostasis, and gut dysbiosis are thought to be involved in disease progression, while bile acids and their receptors may be novel therapeutic targets.
Sheila Flemingsfleming1@neomed.eduNEOMED
Alexander Galazyukagalaz@neomed.eduNEOMEDNeuroscience of hearing.
Rebecca Germanrgerman@neomed.eduNEOMEDNeurophysiology and biomechanics. Regulation of feeding and pathophysiology of dysphagia.
Adam Goodwillagoodwill@neomed.eduNEOMEDMechanisms of coronary flow control, studies of cardiac function and identification of cardioprotective pathways.
Neysa Grider-Potterngriderpotter@neomed.eduNEOMED
Elda Hegmannehegmann@kent.eduKentMore on Hegmann
Tobin Hieronymusthieronymus@neomed.eduNEOMEDPattern and process of skeletal evolution in vertebrates.
Min-Ho Kimmkim15@kent.eduKentNanomedicine strategies towards the treatment of diseases including drug-resistant bacterial infections, chronic wounds, and Alzheimer's disease. More on Kim
Woo Yang Kimwkim2@kent.eduKentBrain development, neurodevelopmental disorders, autism, intellectual disability, brain circuit, neural stem cell. More on Kim
Edgar Kooijmanekooijma@kent.eduKentBiophysics protein/lipid interactions, physical chemistry of lipid structure and function, model membranes, neutral lipid storage (lipid droplets/adipocytes). More on Kooijman
Gary Koskigkoski@kent.eduKentImmune system and cancer, vaccines, molecular mechanisms. More on Koski
Manabu Kurokawamkurokaw@kent.eduKent

More on Kurokawa 

Sangeet Lamichhaneyslamichh@kent.eduKent Our lab is broadly interested in understanding how an organism responds to novel environments. We integrate a variety of interdisciplinary approaches, including comparative ‘omics’ (Genomics, Transcriptomics, Epigenomics and Metabolomics), together with experimental physiology to uncover the molecular basis underlying the processes of adaptation.
Yoon-Kwang Leeylee3@neomed.eduNEOMEDStructure and regulation of nuclear hormone receptors.
Laura Lefflleff@kent.eduKentMolecular ecology of bacteria, bacterial enumeration and identification. More on Leff
Michelle Longworthlongwom@ccf.orgCCF
Hanbin Maohmao@kent.eduKent
Ryota Matsuokamatsuor@ccf.orgCCFDevelopmental neuroscience, brain barriers, brain-blood communications, brain vascular cell heterogeneity, neurovascular morphogenesis, and cerebrovascular diseases. 
Jennifer McDonoughjmcdonou@kent.eduKentRegenerative medicine, mitochondrial dysfunction and epigenetic mechanisms in multiple sclerosis.
Jeffrey Mellottjmellott@neomed.eduNEOMEDAge-related changes to inhibitory circuitry in the auditory pathways. 
Michael Modelmmodel@kent.eduKentApoptosis, cell water and volume regulation, membrane potential. More on Model
Aleisha Mooreamoor149@kent.eduKentThe Moore lab aims to define and understand neuronal networks regulating gonadotropin-releasing hormone (GnRH) neurons, the final output cells in the brain controlling fertility. Currently, we are funded by the National Institutes of Health to investigate whether changes in the regulation of GnRH neurons by cells co-expressing the neuropeptides Kisspeptin, Neurokinin B and Dynorphin (aka KNDy neurons) leads to infertility in polycystic ovary syndrome (PCOS), the most common endocrinopathy in women worldwide. To achieve this, we use a preclinical model of PCOS combined with genetic, anatomical, and functional tools to identify and analyze how changes within KNDy neurons and associated networks lead to the development of PCOS symptoms.
Xiaozhen Mouxmou@kent.eduKentMetatranscriptomics of bacteria, pathogens in ecosystem. More on Mou
Devin Muellerdmuell10@kent.eduKentNeural mechanisms of learning and memory that underlie drug use and emotional regulation. More on Mueller
Colleen Novakcnovak13@kent.eduKentNeural and endocrine mechanisms of activity thermogenesis in obesity. More on Novak
Christine O'Connoroconnoc6@ccf.orgCCF
Vahagn Ohanyanvohanyan@neomed.eduNEOMED
Heather O'Learyholeary@neomed.eduNEOMED
Moses Oyewumimoyewumi@neomed.eduNEOMEDDrug delivery, nanotechnology, cancer, neurodegenerative diseases.
Nikhil Panickerpanickn@ccf.orgCCF
Richard Pietrpiet@kent.eduKentNeurophysiological mechanisms involved in regulating the activity of the gonadotropin releasing hormone (GnRH) neurons and their contributions to biological timing and fertility. More on Piet
Helen Piontkivskaopiontki@kent.eduKentComparative and evolutionary genomics, bioinformatics, molecular evolution. More on Piontkivska
Gunnar Poplawskipoplawg@ccf.orgCCFTranslational therapies for neurodegenerative diseases, stem cell and gene therapies for spinal cord injury, in vitro and in vivo models of glioblastomas, hIPSC derived neurons to study regeneration. 
Priya Ramanpraman@neomed.eduNEOMEDMy lab is interested in the cellular and molecular mechanisms underlying vascular complications and Alzheimer's disease-related dementia associated with diabetes and obesity. We are studying the role of a post-translational protein modification (O-Glycosylation) and a proatherogenic matricellular protein (Thrombospondin-1) in vascular smooth muscle cell phenotypic changes and seeking to understand how targets contributed to vascular and cognitive anomalies in metabolic disorders. 
Erin Reed-Geaghan

ereedgeaghan@neomed.edu

 

NEOMEDMy lab is interested in the role of the immune system in Alzheimer’s disease (AD). Specifically, we seek to understand the ways in which the brain’s resident immune cells, microglia, contribute to the neuroinflammatory processes driving neurodegeneration. We believe microglia from men and women respond differently in AD, contributing to the sex differences in disease onset and progression, and we’re working on identifying the reasons for these differences. We are also interested in how these cells communicate with the circulating peripheral immune system, and the ways in which these interactions affect disease progression
Merri Rosenmrosen@neomed.eduNEOMEDEffects of developmental stress and hearing loss on auditory perception and neural circuity. 
Thorsten-Lars Schmidttschmi21@kent.eduKentDNA nanotechnology-based tools and materials for single-molecule biophysics and nanomedicine.  More on Schmidt
Brett Schofieldbschofie@neomed.eduNEOMEDFunctional anatomy of auditory pathways.
Sharad Shanbhagsshanbhag@neomed.eduNEOMEDThe amygdala's role in vocal communication. 
Woo-Shik Shin (Austin)wshin@neomed.eduNEOMEDNovel combination antibacterial therapy against drug resistance ESKAPE pathogens. Drug repurposing and combinational approach to block abnormal protein aggregation in Alzheimer’s disease. Our lab focuses on computational structure-based drug design and drug delivery system for Alzheimer's, Parkinson's disease and other degenerative disorders. Current research is driven by two key topics: How to develop new therapeutic approach for neurodegenerative and other brain diseases? How to design the blood-brain barrier shuttle peptides with neuronal specificity? 
Apollo Stacystacya2@ccf.orgCCF
J.G.M. Thewissenthewisse@neomed.eduNEOMEDMammalian anatomy and evolution, morphological adaptations such as those for swimming and flight.
Anthony Tosiatosi@kent.eduKentMore on Tosi
Brian Trevellinebtrevell@kent.eduKent
Sean Veneysveney@kent.eduKentBehavioral neuroendocrinology, sexual differentiation of the brain, syrinx anatomy, neuroethology of birdsong. More on Veney
Xinwen Wangxwang2@neomed.eduNEOMEDOne size does not fit all. For many patients, standard drug treatment might not work or even trigger life-threatening adverse reactions. There is an urgent clinical need to provide tailored therapy for patients. Our laboratory focuses on applying pharmaco-omics tools (i.e. pharmacogenomics, proteomics and metabolomics) to identify both genetic and non-genetic factors contributing to the interindividual variability related to disease risks and drug therapies. Our research is expected to improve the efficacy and safety of drugs by identifying biomarkers that can predict individual drug responses, revealing novel drug targets and translating these findings into clinical precision pharmacotherapy. 
Yuxin Wangwangy7@ccf.orgCCF
Jeffrey Wenstrupjjw@neomed.eduNEOMEDNeural mechanisms of hearing, acoustic communication, including emotional responses to sound.
Jessica Williamswilliaj39@ccf.orgCCF
Bradley Wintersbwinters@neomed.eduNEOMEDCellular neurophysiology of brainstem sound localization circuits that process timing and intensity differences between the two ears.
Jesse Youngjwyoung@neomed.eduNEOMEDComparative and developmental biomechanics of locomotion.
Ping Zhangpzhang@neomed.eduNEOMED
Yaorong Zhengyzheng7@kent.eduKent